Influence of interleukin-8 polymorphism on endometriosis-related pelvic pain.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 27 01 2023
revised: 26 05 2023
accepted: 11 07 2023
medline: 25 9 2023
pubmed: 20 7 2023
entrez: 19 7 2023
Statut: ppublish

Résumé

Endometriosis presents a pro-inflammatory microenvironment influenced by cytokines, such as interleukin (IL)-8, which expression may be influenced by genetic polymorphisms. Therefore, we aimed to investigate the role of interleukin (IL)-8 rs4073 polymorphism in endometriosis' development and its related symptoms. A case-control study was conducted with 207 women with endometriosis and 193 healthy controls. Polymorphism was genotyped using a TaqMan validated assay. Associations were evaluated by binary logistic regression, using odds ratios (OR) and 95 % confidence intervals (CI), and P ≤ 0.05 was considered significant. Cases were younger (36 ± 6.8 versus 39 ± 8.4) and had lower body mass index (26.5 ± 5.3 versus 35.7 ± 6.3 Kg/m

Identifiants

pubmed: 37468423
pii: S0198-8859(23)00113-1
doi: 10.1016/j.humimm.2023.07.004
pii:
doi:

Substances chimiques

Interleukin-8 0
Interleukins 0
CXCL8 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-566

Informations de copyright

Copyright © 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jéssica Vilarinho Cardoso (JV)

Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil.

Daniel Escorsim Machado (DE)

Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil.

Mayara Calixto da Silva (MC)

Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil.

Matheus Pereira de Mello (MP)

Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil.

Plinio Tostes Berardo (PT)

Serviço de Ginecologia, Hospital Federal dos Servidores do Estado (HFSE), Rio de Janeiro, Brazil.

Rui Medeiros (R)

Grupo de Oncologia Molecular e Patologia Viral, Centro de Investigação do Instituto Português de Oncologia do Porto (IPO Porto)/Dep. Patologia e Medicina Laboratorial, Patologia Clínica SV/ (Rede de Investigação em Saúde)/Porto, Centro Abrangente de Oncologia, Porto, Portugal.

Jamila Alessandra Perini (JA)

Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil. Electronic address: jamilaperini@yahoo.com.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH